BeOne Medicines Ltd. (ONC) stock
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/302571% above fair value
$413.26+1.97 (+0.48%)
Close on Nov 17, 2026Market cap $46.99BP/E 73.9Yield –
BeOne Medicines enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
BeOne Medicines's enterprise value was $43.51B on Nov 11, 2026, against $34.46B a year earlier. Over the last 5 years it ranged from $8.45B to $43.51B, with a median of $19.94B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $43.51B | +43.2% |
| 2025 | Dec 31, 2025 | $30.38B | +68.4% |
| 2024 | Dec 31, 2024 | $18.04B | +11.1% |
| 2023 | Dec 29, 2023 | $16.23B | -15.8% |
| 2022 | Dec 30, 2022 | $19.29B | -12.4% |
| 2021 | Dec 31, 2021 | $22.01B | +15.8% |
| 2020 | Dec 31, 2020 | $19.00B | – |
| 2019 | Dec 31, 2019 | -$111.75M | -101.8% |
| 2018 | Dec 31, 2018 | $6.35B | +71.6% |
| 2017 | Dec 29, 2017 | $3.70B | +364.1% |
| 2016 | Dec 30, 2016 | $797.14M | – |
See a number that looks wrong?